In head and neck squamous cell carcinoma cells, CSC‐3436 is reported to inhibit the Twist expression to downregulate the expression of B cell‐specific Moloney murine leukemia virus integration site 1 (Bmi1), a biomarker of tumor‐initiated cells. The gene discussed is TWIST1; the disease is neoplasm.